An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

NCT05685732 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit/Hyperactivity Disorder

Interventions

DRUG: Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
OTHER: placebo

Sponsor

Corium, Inc.

Collaborators

[object Object]
[object Object]
[object Object]